Daniel Lauren C, Venella Kimberly L, Woodard Kelsey, Poliakova Polina, Gross J Yael, Bercovitz Iris N, Moore Dirk, Barakat Lamia P, Freedman Jason L
Department of Psychology, Rutgers University, Camden, New Jersey, USA.
Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Pediatr Blood Cancer. 2024 Apr;71(4):e30832. doi: 10.1002/pbc.30832. Epub 2024 Jan 10.
Patients undergoing hematopoietic stem cell transplant (HSCT) experience barriers to quality sleep. Frequent vital sign checks are necessary early posttransplant given risk of complications but can disrupt sleep. This study tested feasibility and acceptability of extending time between checking vitals (EVs) from every 4 to every 6 h to improve sleep.
HSCT patients ages 8-21 years (N = 50, mean age = 14.06, SD = 3.58) and their caregivers were enrolled 1-2 days prior to transplant, and 40 patients completed the 15-day study (NCT04106089). Patients wore an actigraph to estimate sleep and provided self- and caregiver-report of sleep. Sleep was observed for nights 0 to +4 posttransplant, and patients were then randomized to EVs either Days +5 to +9 or +10 to +14. Patients were assessed daily for medical eligibility to receive EVs; on days patients were eligible, nightshift nurses (N = 79) reported EV acceptability.
Of 200 potential nights for EVs (5 nights x 40 patients), patients were eligible for EVs on 126 nights (63% of eligible nights), and patients received EVs on 116 (92%) of eligible nights. Most patients received EVs ≥3 nights (n = 26, 65%, median = 3 nights). Most patients (85%), caregivers (80%), and nurses (84%) reported that patients used the additional 2 h during EVs for sleep, with reporters indicating moderate to high acceptability. There was preliminary evidence of efficacy indicated by caregiver-reported sleep disturbance and actigraphy-estimated improvements in sleep efficiency during EVs.
Extending time between vitals checks is highly acceptable to patients, caregivers, and nurses, and may offer a feasible approach to improve sleep in pediatric HSCT.
接受造血干细胞移植(HSCT)的患者在获得优质睡眠方面存在障碍。鉴于移植后早期存在并发症风险,频繁进行生命体征检查是必要的,但这可能会干扰睡眠。本研究测试了将生命体征检查间隔时间(EVs)从每4小时延长至每6小时以改善睡眠的可行性和可接受性。
8至21岁的HSCT患者(N = 50,平均年龄 = 14.06,标准差 = 3.58)及其护理人员在移植前1至2天入组,40名患者完成了为期15天的研究(NCT04106089)。患者佩戴活动记录仪来估计睡眠情况,并提供自我和护理人员的睡眠报告。在移植后第0至 +4晚观察睡眠情况,然后将患者随机分为在第 +5至 +9天或 +10至 +14天进行EVs。每天评估患者接受EVs的医疗适宜性;在患者符合条件的日子里,夜班护士(N = 79)报告EVs的可接受性。
在200个可能进行EVs的夜晚(5晚×40名患者)中,患者在126个夜晚符合进行EVs的条件(占符合条件夜晚的63%),并且患者在116个(92%)符合条件的夜晚接受了EVs。大多数患者接受EVs≥3晚(n = 26,65%,中位数 = 3晚)。大多数患者(85%)、护理人员(80%)和护士(84%)报告称,患者在EVs期间利用额外的2小时进行睡眠,报告者表示接受程度为中度至高。有初步证据表明,护理人员报告的睡眠干扰和活动记录仪估计的EVs期间睡眠效率提高显示出了疗效。
延长生命体征检查间隔时间对于患者、护理人员和护士来说是高度可接受的,并且可能为改善儿科HSCT患者的睡眠提供一种可行的方法。